PHARMACY

Press enter to search
Close search
Open Menu

PHARMACY

News and information on retail pharmacy, including generic drugs, branded drugs, specialty pharmacy medications, pharmacy technology and legislative updates.

CVS Pharmacy expands benefits, safety measures for employees

CVS Pharmacy announced new employee benefits and safety measures to keep employees and customers safe during the COVID-19 pandemic.

Ninety percent of local pharmacists are reporting a shortage of hydroxychloroquine, according to an NCPA survey.

NACDS's ad highlights how pharmacists have been rising up to help customers and their communities during the COVID-19 pandemic.

Camber has expanded its offerings to include Glycerin liquid and a line of three syrups.

CVS exterior.

CVS Health and its foundations are providing financial investments to help communities and employees facing COVID-19 pandemic-related hardships.

Vials containing injection.

J&J and the U.S. government are committing more than $1 billion for research and development of a novel coronavirus vaccine, which could be ready for emergency use by early 2021.

A pharmacy stock room.

Zydus Cadila's generic Lamictal will be available in six dosage strengths.

Higi is launching a partnership with Babylon Health, to offer its users a free, self-service, online COVID-19 digital symptom checker, as well as clinical guidance on when to seek testing and potential treatment.

Kinney Drugs will have Clayton Distillery's liquid hand sanitizer in all stores by April 6.

Kinney Drugs exterior.

All 97 Kinney Drugs locations have acrylic shields installed in the pharmacy drop-off and pick-up areas, as well as at the front registers, to protect customers and employees.

According to a survey commissioned by NACDS, 86% of voters say pharmacists should be allowed to provide tests for COVID-19, and the same number say pharmacists should be able to administer a vaccine once developed.

A pharmacist holding a prescription box.

Adderall XR, including generic versions, have a market value of approximately $1.3 billion for the 12 months ending January 2020, according to IQVIA.

Bartell's storefront.

Bartell's is taking additional safety measures to protect employees and customers during the COVID-19 pandemic.

As it moves into its second century in business, Upsher-Smith Labs is focusing on innovating and growing its product offerings while maintaining its high standards.

Generic pill bottles.

Amneal is donating one million hydroxychloroquine sulfate tablets to Texas, following a donation of two million tablets to New York.

A pharmacist handing a prescription to a patient.

NACDS praised Secretary of HHS Alex Azar's letter to the nation’s governors asking for assistance to extend the capacity of the healthcare workforce to address the pandemic.

Beaumont and Henry Ford hospitals in Detroit have received 22,500 pairs of gloves each from CDMA.

CVS Health is taking additional steps to limit stockpiling of drugs that are used to treat chronic conditions as interest in off-label use of these medicines to treat COVID-19 grow.

Independents are fighting industry headwinds and exploring new revenue streams.

Major retailers are awarding bonuses, expanding employee benefits and launching unprecedented hiring drives as they respond to the COVID-19 crisis.

CVS Health's first COVID-19 testing site in Shrewsbury, Mass. will initially focus on first responders and health care workers.

A pharmacist handing a prescription to a patient.

Several pharmaceutical companies are making a commitment to respond to COVID-19 by donating or accelerating the production of hydroxychloroquine.

The FIP has issued updated global guidance for pharmacists in community, hospital and clinical biology on COVID-19, replacing its first guidance released last month.

Mylan will enable generic applicants to be eligible for FDA approval if Kaletra is found effective in treating COVID-19.

The words approved in red capitalzed letters.

Zydus Cadila's generic Rytary is indicated to treat Parkinson's disease.

Show More